PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Cinnamtannin B1 exhibited strong antiproliferative effects, inducing cell cycle arrest and apoptosis in HepG2 cells [PMID:25857215].
Cinnamtannin B1 exhibited strong antiproliferative effects against Siha cell lines [PMID:25857215].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39067775 (2024) — Methanolic extracts of litchi (Litchi chinensis Sonn.): A novel approach of targeting glucose-6-phosphate dehydrogenase for liver cancer therapy. · Toxicon : official journal of the International Society on Toxinology
- 2.PMID: 38258010 (2024) — Effectiveness of Volatiles Emitted by Streptomyces abikoensis TJGA-19 for Managing Litchi Downy Blight Disease. · Microorganisms
- 3.PMID: 25857215 (2015) — Identification of phenolics in litchi and evaluation of anticancer cell proliferation activity and intracellular antioxidant activity. · Free radical biology & medicine